Cargando…
Randomized trial of l-serine in patients with hereditary sensory and autonomic neuropathy type 1
OBJECTIVE: To evaluate the safety and efficacy of l-serine in humans with hereditary sensory autonomic neuropathy type I (HSAN1). METHODS: In this randomized, placebo-controlled, parallel-group trial with open-label extension, patients aged 18–70 years with symptomatic HSAN1 were randomized to l-ser...
Autores principales: | Fridman, Vera, Suriyanarayanan, Saranya, Novak, Peter, David, William, Macklin, Eric A., McKenna-Yasek, Diane, Walsh, Kailey, Aziz-Bose, Razina, Oaklander, Anne Louise, Brown, Robert, Hornemann, Thorsten, Eichler, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345118/ https://www.ncbi.nlm.nih.gov/pubmed/30626650 http://dx.doi.org/10.1212/WNL.0000000000006811 |
Ejemplares similares
-
Clinical and metabolic consequences of L-serine supplementation in hereditary sensory and autonomic neuropathy type 1C
por: Auranen, Mari, et al.
Publicado: (2017) -
Natural history and biomarkers in hereditary sensory neuropathy type 1
por: Fridman, Vera, et al.
Publicado: (2015) -
Hereditary and Sensory Autonomic Neuropathies
por: Khaledi, Mojdeh, et al.
Publicado: (2012) -
Keratoconus associated with hereditary sensory and autonomic neuropathy II
por: Shah, Zalak, et al.
Publicado: (2022) -
Genetic landscape of congenital insensitivity to pain and hereditary sensory and autonomic neuropathies
por: Lischka, Annette, et al.
Publicado: (2023)